|Bid||52.00 x 17000|
|Ask||54.50 x 16200|
|Day's Range||52.00 - 52.00|
|52 Week Range||46.60 - 60.00|
|Beta (5Y Monthly)||0.22|
|PE Ratio (TTM)||32.89|
|Forward Dividend & Yield||1.58 (2.94%)|
|Ex-Dividend Date||Mar 03, 2022|
|1y Target Est||N/A|
A look at the shareholders of ASX Limited ( ASX:ASX ) can tell us which group is most powerful. Institutions will often...
Lofthouse, who will be starting her new role from Aug. 1 is entitled to an annual fixed remuneration of A$2 million ($1.44 million), the same as Stevens' yearly pay as seen in the 2021 annual report, ASX said. "I am looking forward to helping shape ASX's future as we continue our transformation and leverage our technology platform to deliver further value," said Lofthouse, who was also selected as one of the World Federation of Exchanges Women Leaders for 2021.
SOUTH SAN FRANCISCO, Calif., May 02, 2022 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc., (Nasdaq: LYEL), a T-cell reprogramming company dedicated to the mastery of T cells to cure patients with solid tumors, announced today that two abstracts have been accepted for poster presentations at the 25th Annual Meeting of the American Society of Gene & Cell Therapy, scheduled for May 16 - May 19, 2022, in Washington, DC. The presentations will highlight preclinical data characterizing two investigationa